Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
4DMedical Ltd ( (AU:4DX) ) has provided an announcement.
4DMedical Ltd has announced the quotation of 2,913,928 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code 4DX, effective from September 18, 2025. This move is part of the company’s strategy to leverage convertible securities, potentially enhancing its market presence and providing additional capital to support its operations and growth initiatives.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on innovative respiratory imaging solutions. The company is known for its advanced lung imaging technology, which aims to enhance the diagnosis and treatment of respiratory conditions.
Average Trading Volume: 5,549,995
Technical Sentiment Signal: Buy
Current Market Cap: A$927.8M
See more insights into 4DX stock on TipRanks’ Stock Analysis page.